(-)-alpha-phellandrene increases expression ISO PARP14 (Homo sapiens) 6480464 alpha phellandrene results in increased expression of PARP14 mRNA CTD PMID:25075043 (1->4)-beta-D-glucan multiple interactions ISO Parp14 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PARP14 mRNA CTD PMID:36331819 1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of PARP14 mRNA CTD PMID:27840820 1,2-dimethylhydrazine affects expression ISO Parp14 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine affects the expression of PARP14 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO PARP14 (Homo sapiens) 6480464 Estradiol results in increased expression of PARP14 mRNA CTD PMID:21185374 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PARP14 mRNA CTD PMID:32741896 17beta-estradiol multiple interactions ISO PARP14 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of PARP14 mRNA CTD PMID:30165855 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PARP14 mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Parp14 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO PARP14 (Homo sapiens) 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO PARP14 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Parp14 (Mus musculus) 6480464 2 more ... CTD PMID:30294300 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:23829299 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Parp14 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO Parp14 (Mus musculus) 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Parp14 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of PARP14 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PARP14 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PARP14 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO PARP14 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of PARP14 mRNA CTD PMID:20106945 and PMID:21632981 2,4,6-tribromophenol decreases expression ISO PARP14 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 3,3',5,5'-tetrabromobisphenol A decreases expression ISO PARP14 (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of PARP14 protein CTD PMID:31675489 4,4'-sulfonyldiphenol increases expression ISO Parp14 (Mus musculus) 6480464 bisphenol S results in increased expression of PARP14 mRNA CTD PMID:30951980 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression EXP 6480464 Oxazolone results in increased expression of PARP14 mRNA CTD PMID:21893156 5-fluorouracil increases expression ISO PARP14 (Homo sapiens) 6480464 Fluorouracil results in increased expression of PARP14 mRNA CTD PMID:17039268 acetamide affects expression EXP 6480464 acetamide affects the expression of PARP14 mRNA CTD PMID:31881176 aconitine decreases expression EXP 6480464 Aconitine results in decreased expression of PARP14 protein CTD PMID:33236894 aflatoxin B1 increases expression ISO Parp14 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of PARP14 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO PARP14 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of PARP14 gene CTD PMID:27153756 aldehydo-D-glucose multiple interactions ISO Parp14 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PARP14 mRNA CTD PMID:37567420 all-trans-retinoic acid increases expression ISO PARP14 (Homo sapiens) 6480464 Tretinoin results in increased expression of PARP14 mRNA CTD PMID:23830798 and PMID:33167477 alpha-phellandrene increases expression ISO PARP14 (Homo sapiens) 6480464 alpha phellandrene results in increased expression of PARP14 mRNA CTD PMID:25075043 benzo[a]pyrene decreases expression ISO Parp14 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of PARP14 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO PARP14 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of PARP14 intron CTD PMID:30157460 benzo[a]pyrene increases expression ISO PARP14 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of PARP14 mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I increases expression ISO PARP14 (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 benzo[e]pyrene increases methylation ISO PARP14 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of PARP14 intron CTD PMID:30157460 bisphenol A increases expression ISO Parp14 (Mus musculus) 6480464 bisphenol A results in increased expression of PARP14 mRNA CTD PMID:26063408 bisphenol A decreases expression ISO PARP14 (Homo sapiens) 6480464 bisphenol A results in decreased expression of PARP14 protein CTD PMID:31675489 bisphenol A multiple interactions ISO PARP14 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PARP14 gene CTD PMID:31601247 bisphenol A decreases methylation ISO PARP14 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of PARP14 gene CTD PMID:31601247 bisphenol A increases expression ISO PARP14 (Homo sapiens) 6480464 bisphenol A results in increased expression of PARP14 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PARP14 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PARP14 mRNA CTD PMID:30816183 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PARP14 mRNA CTD PMID:25181051 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of PARP14 mRNA CTD PMID:32479839 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of PARP14 mRNA CTD PMID:24136188 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PARP14 mRNA CTD PMID:33453195 carbon nanotube increases expression ISO Parp14 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons and Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of PARP14 mRNA CTD PMID:30744511 chromium(6+) affects expression ISO Parp14 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of PARP14 mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression ISO Parp14 (Mus musculus) 6480464 Ciguatoxins affects the expression of PARP14 mRNA CTD PMID:18353800 cisplatin increases expression ISO PARP14 (Homo sapiens) 6480464 Cisplatin results in increased expression of PARP14 mRNA CTD PMID:27594783 clofibrate decreases expression ISO Parp14 (Mus musculus) 6480464 Clofibrate results in decreased expression of PARP14 mRNA CTD PMID:23811191 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of PARP14 mRNA CTD PMID:24386269 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of PARP14 mRNA CTD PMID:26577399 and PMID:27523638 D-glucose multiple interactions ISO Parp14 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PARP14 mRNA CTD PMID:37567420 decabromodiphenyl ether increases expression ISO PARP14 (Homo sapiens) 6480464 decabromobiphenyl ether results in increased expression of PARP14 protein CTD PMID:31675489 dioxygen multiple interactions ISO Parp14 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PARP14 mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PARP14 mRNA] and [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PARP14 mRNA CTD PMID:33729688 diquat decreases expression ISO Parp14 (Mus musculus) 6480464 Diquat results in decreased expression of PARP14 mRNA CTD PMID:36851058 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PARP14 mRNA CTD PMID:29391264 ethanol affects expression ISO Parp14 (Mus musculus) 6480464 Ethanol affects the expression of PARP14 mRNA CTD PMID:26730594 ethyl methanesulfonate increases expression ISO PARP14 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of PARP14 mRNA CTD PMID:23649840 fenthion decreases expression ISO Parp14 (Mus musculus) 6480464 Fenthion results in decreased expression of PARP14 mRNA CTD PMID:34813904 finasteride decreases expression EXP 6480464 Finasteride results in decreased expression of PARP14 mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of PARP14 mRNA CTD PMID:24793618 fructose multiple interactions ISO Parp14 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PARP14 mRNA CTD PMID:37567420 fulvestrant multiple interactions ISO PARP14 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PARP14 gene CTD PMID:31601247 furan decreases expression EXP 6480464 furan results in decreased expression of PARP14 mRNA CTD PMID:25539665 and PMID:26194646 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PARP14 mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PARP14 mRNA CTD PMID:33387578 glucose multiple interactions ISO Parp14 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PARP14 mRNA CTD PMID:37567420 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of PARP14 mRNA CTD PMID:24395379 glyphosate multiple interactions ISO Parp14 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PARP14 mRNA CTD PMID:37567420 hydralazine multiple interactions ISO PARP14 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of PARP14 mRNA CTD PMID:17183730 inulin multiple interactions ISO Parp14 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PARP14 mRNA CTD PMID:36331819 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of PARP14 mRNA CTD PMID:35283115 lipopolysaccharide multiple interactions ISO Parp14 (Mus musculus) 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of PARP14 mRNA] CTD PMID:25890327 lipopolysaccharide multiple interactions ISO PARP14 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PARP14 mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO PARP14 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of PARP14 mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO Parp14 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of PARP14 mRNA CTD PMID:25890327 manganese atom increases expression ISO Parp14 (Mus musculus) 6480464 Manganese results in increased expression of PARP14 mRNA CTD PMID:23499988 manganese(0) increases expression ISO Parp14 (Mus musculus) 6480464 Manganese results in increased expression of PARP14 mRNA CTD PMID:23499988 methapyrilene increases methylation ISO PARP14 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of PARP14 intron CTD PMID:30157460 methidathion decreases expression ISO Parp14 (Mus musculus) 6480464 methidathion results in decreased expression of PARP14 mRNA CTD PMID:34813904 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons and Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of PARP14 mRNA CTD PMID:30744511 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of PARP14 mRNA CTD PMID:24136188 nickel atom increases expression ISO PARP14 (Homo sapiens) 6480464 Nickel results in increased expression of PARP14 mRNA CTD PMID:24768652 and PMID:25583101 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PARP14 mRNA CTD PMID:25729387 ozone multiple interactions ISO Parp14 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PARP14 mRNA CTD PMID:34911549 paracetamol decreases expression ISO PARP14 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of PARP14 mRNA CTD PMID:21420995 and PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PARP14 mRNA CTD PMID:32479839 and PMID:33387578 PCB138 multiple interactions ISO Parp14 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 pentachlorophenol increases expression ISO Parp14 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of PARP14 mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid decreases expression ISO PARP14 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of PARP14 mRNA CTD PMID:27153767 perfluorooctane-1-sulfonic acid multiple interactions ISO Parp14 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PARP14 mRNA more ... CTD PMID:36331819 pirinixic acid multiple interactions ISO Parp14 (Mus musculus) 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of PARP14 mRNA CTD PMID:20813756 pirinixic acid decreases expression ISO Parp14 (Mus musculus) 6480464 pirinixic acid results in decreased expression of PARP14 mRNA CTD PMID:17426115 more ... resveratrol multiple interactions ISO PARP14 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of PARP14 mRNA CTD PMID:23557933 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PARP14 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO PARP14 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PARP14 mRNA CTD PMID:35811015 silicon dioxide decreases expression ISO Parp14 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of PARP14 mRNA CTD PMID:19073995 silver atom decreases expression ISO Parp14 (Mus musculus) 6480464 Silver results in decreased expression of PARP14 mRNA CTD PMID:27131904 silver(0) decreases expression ISO Parp14 (Mus musculus) 6480464 Silver results in decreased expression of PARP14 mRNA CTD PMID:27131904 Soman increases expression EXP 6480464 Soman results in increased expression of PARP14 mRNA CTD PMID:19281266 sulindac decreases expression EXP 6480464 Sulindac results in decreased expression of PARP14 mRNA CTD PMID:24136188 sunitinib decreases expression ISO PARP14 (Homo sapiens) 6480464 Sunitinib results in decreased expression of PARP14 mRNA CTD PMID:31533062 tamoxifen affects expression ISO Parp14 (Mus musculus) 6480464 Tamoxifen affects the expression of PARP14 mRNA CTD PMID:20937368 temozolomide increases expression ISO PARP14 (Homo sapiens) 6480464 Temozolomide results in increased expression of PARP14 mRNA CTD PMID:31758290 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PARP14 mRNA CTD PMID:32741896 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PARP14 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PARP14 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PARP14 mRNA CTD PMID:25729387 trichostatin A increases expression ISO PARP14 (Homo sapiens) 6480464 trichostatin A results in increased expression of PARP14 mRNA CTD PMID:24935251 triclosan increases expression ISO PARP14 (Homo sapiens) 6480464 Triclosan results in increased expression of PARP14 mRNA CTD PMID:30510588 Triptolide increases expression EXP 6480464 triptolide results in increased expression of PARP14 protein CTD PMID:32519852 troglitazone decreases expression ISO Parp14 (Mus musculus) 6480464 troglitazone results in decreased expression of PARP14 mRNA CTD PMID:28973697 trovafloxacin increases expression ISO Parp14 (Mus musculus) 6480464 trovafloxacin results in increased expression of PARP14 mRNA CTD PMID:35537566 tungsten decreases expression ISO Parp14 (Mus musculus) 6480464 Tungsten results in decreased expression of PARP14 mRNA CTD PMID:30912803 urethane decreases expression ISO PARP14 (Homo sapiens) 6480464 Urethane results in decreased expression of PARP14 mRNA CTD PMID:28818685 valproic acid multiple interactions ISO PARP14 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of PARP14 mRNA CTD PMID:17183730 valproic acid affects expression ISO PARP14 (Homo sapiens) 6480464 Valproic Acid affects the expression of PARP14 mRNA CTD PMID:25979313 valproic acid decreases expression ISO PARP14 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of PARP14 mRNA CTD PMID:23179753 vancomycin decreases expression ISO Parp14 (Mus musculus) 6480464 Vancomycin results in decreased expression of PARP14 mRNA CTD PMID:18930951 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of PARP14 mRNA CTD PMID:23034163